Drawing for MYBINX

USPTO serial 88076097

MYBINX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CROWLEY, SEAN MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYBINX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vincent J. Badolato

Vincent J. Badolato BROWN RUDNICK LLP601 Thirteenth Street NW Suite 600Washington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005medical conditions screening kits composed of medical diagnostic reagents and assays for testing of bodily fluids for use in detection STD's and human papillomavirus and prostate-specific antigen, the aforementioned being for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationsACTIVE—
010Medical diagnostic kits for medical purposes consisting of medical specimen collection devices for testing the presence of biomarkers indicative of disease, medical conditions and levels of substances, namely, STDs, cancer genetic markers, fertility, and lifestyle concerns; Instrument and apparatus system for medical diagnostic use consisting of medical specimen collection devices, an electronic instrument, a disposable cartridge on which the test is performed in conjunction with the instrument and a range of medical devices used for sample collection to provide the test material, all sold to be used as a unit; the aforementioned systems are for use in testing for the presence of infection and disease state health markers in human samples in clinical applications, in animal samples in veterinary applications, and in testing for the presence of infection-causing microorganisms in environmental applicationsACTIVE—
044Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for biomarkers indicative of disease, STDs, cancer, genetic anomalies and disorders, fertility, and lifestyle issues, namely, collecting biological samples for in-home testing for medical purposes, providing testing and diagnostic services thereto for medical purposes, and medical information services, namely, reporting test results to customers test kitsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 28, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 28, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 13, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 13, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 13, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 13, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 13, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 13, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2020EX2GSOU EXTENSION 2 GRANTED—
Feb 21, 2020EXT2SOU EXTENSION 2 FILED—
Feb 21, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 21, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 21, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2019EX1GSOU EXTENSION 1 GRANTED—
Aug 13, 2019EXT1SOU EXTENSION 1 FILED—
Aug 13, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 28, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 27, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 21, 2018CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Nov 21, 2018ALIEASSIGNED TO LIE—
Nov 21, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 21, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 21, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 21, 2018DOCKASSIGNED TO EXAMINER—
Aug 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance